. https : / / doi. org / 1 0. 1 0 0 7 / s 0 0 4 1 5 - 0 1 3 - 7 1 8 9 - 3. vazquez - mojena y, perez - rodriguez r, ziemann u. neurophys53. schniepp r, huppert a, decker j, schenkel f, schlick c, rasoul iological features in spinocerebellar ataxia type 2 : prospects for a, et al. fall prediction in neurological gait disorders : differential novel biomarkers. clin neurophysiol. 2022 ; 135 : 1 – 12. https : / / doi contributionsfromclinicalassessment, gait analysis, and daily -. o r g / 1 0. 1 0 1 6 / j. c l i n p h. 2 0 2 1. 1 2. 0 0 5. life mobility monitoring. j neurol. 2021 ; 268 : 3421 – 34. https : / / do69. kimdh, kim r, lee jy, lee km. clinical, imaging, and laborai. o r g / 1 0. 1 0 0 7 / s 0 0 4 1 5 - 0 2 1 - 1 0 5 0 4 - x. tory markers of premanifest spinocerebellar ataxia 1, 2, 3, and 6 : 54. ilg w, muller b, faber j, van gaalen j, hengel h, vogt ir, et a systematic review. j clin neurol. 2021 ; 17 : 187 – 99. https : / / doi. al. digitalgaitbiomarkersallowtocapture1 - yearlongitu - org / 1 0. 3 9 8 8 / j c n. 2 0 2 1. 1 7. 2. 1 8 7. dinal change in spinocerebellar ataxia type 3. mov disord. 70. van de warrenburg bpc, notermans nc, schelhaas hj, van alfen 2022 ; 37 : 2295 – 301. https : / / doi. org / 1 0. 1 0 0 2 / m d s. 2 9 2 0 6. n, sinke rj, knoers nvam, et al. peripheral nerve involvement 55. seemann j, daghsen l, cazier m, lamy j -